4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-24-042541
Chief Scientific Officer sold 76,920 shares at $0.56 ($43,306)
- Chief Scientific Officer acquired 230,645 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taveras Arthur Chief Scientific Officer | 2024-10-04 | Grant or award | +230,645 | 464,946 | D | ||
| Taveras Arthur Chief Scientific Officer | 2024-10-07 | Sale | −76,920 | $0.56 | $43,306 | 388,026 | D |
| Open-market sales · 76,920 sh · avg $0.56 · $43,306 | |||||||
Loading xslF345X05/wk-form4_1728420235.xml…